Denis Chem Lab Limited

BSE: DENISCHEM537536ISIN INE051G01012

Healthcare
Pharmaceuticals

Share price

₹60.01-2.05 (-3.30%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹93.00
52W low: ₹56.10
Off 52W high: -35.47%
1M return: -10.78%
3M return: -14.11%
6M return: -22.05%
1Y return: -34.58%
20D avg volume: 6,596
50 DMA: ₹66.93
200 DMA: ₹72.12

Key ratios Standalone

Market cap: ₹83.27 Cr
Current price: ₹60.01
52W high / low: ₹93.00 / ₹56.10
Face value: ₹10.00
P/E: 16.05
P/B: 1.01
EPS (TTM): ₹3.74
Book value / share: ₹59.42
ROE: 6.30%
ROCE: 13.70%
Operating margin: 2.72%
Net margin: -1.45%
Debt / equity: 0.05
Net debt: ₹3.72 Cr
Interest cover: 15.17
Dividend yield: 4.17%
Dividend / share (TTM): ₹2.50
Payout: 66.84%
Cash conversion cycle: 55.3 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	39.35	44.00	46.76	45.52	46.17	43.28	41.38	42.84	47.82	41.26	—
	0.37	0.45	0.54	0.44	0.65	0.30	1.17	0.30	0.58	0.33	—
	39.72	44.45	47.29	45.96	46.82	43.58	42.56	43.14	48.40	41.58	—
	40.48	41.80	46.15	41.55	43.79	40.26	41.29	40.92	43.69	38.66	—
	21.18	23.83	21.81	21.93	21.09	22.71	19.69	20.62	22.12	20.52	—
	4.33	3.24	2.18	2.54	2.85	3.10	2.25	3.12	3.23	3.41	—
	4.50	4.19	5.04	4.25	4.29	3.58	3.85	4.03	3.99	3.39	—
	0.17	0.11	0.20	0.22	0.23	0.19	0.23	0.07	0.09	0.12	—
	1.66	1.53	1.74	1.83	1.65	1.61	1.73	1.84	1.66	1.63	—
	10.65	10.12	13.54	12.16	13.17	10.32	12.86	11.49	11.17	10.77	—
	-0.76	2.64	1.14	4.41	3.03	3.32	1.27	2.22	4.71	2.92	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-0.76	2.64	1.14	4.41	3.03	3.32	1.27	2.22	4.71	2.92	—
	-0.19	0.60	0.74	1.09	0.81	0.84	0.56	0.46	1.18	0.84	—
	-0.57	2.05	0.40	3.32	2.21	2.48	0.71	1.76	3.53	2.08	—
	-0.41	1.47	0.29	2.39	1.60	1.78	0.51	1.27	2.54	1.50	—
Key metrics
	1.07	4.28	3.08	6.46	4.91	5.12	3.23	4.13	6.46	4.67	—
	2.70%	9.70%	6.60%	14.20%	10.60%	11.80%	7.80%	9.60%	13.50%	11.30%	—
	-1.40%	4.70%	0.90%	7.30%	4.80%	5.70%	1.70%	4.10%	7.40%	5.00%	—
	-0.60%	—	1.40%	—	3.70%	—	1.70%	—	—	—	—
	-14.80%	1.70%	13.00%	6.30%	-3.50%	4.90%	—	—	—	—	—
	-125.80%	-17.30%	-43.70%	88.60%	-37.40%	19.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	175.63	181.72	173.30	—
	1.80	1.92	2.38	—
	177.42	183.64	175.67	—
	169.98	171.75	164.56	—
	88.75	87.54	86.44	—
	12.29	10.66	8.65	—
	17.98	17.16	15.26	—
	0.70	0.84	0.51	—
	6.76	6.84	6.86	—
	46.47	49.20	46.16	—
	7.43	11.90	11.11	—
	0.00	0.00	0.00	—
	7.43	11.90	11.11	—
	2.24	3.49	3.04	—
	5.20	8.41	8.08	—
	3.74	6.06	5.82	—
Key metrics
	14.89	19.58	18.48	—
	8.48%	10.80%	10.70%	—
	2.96%	4.60%	4.70%	—
	—	13.70%	13.50%	—
	1.13%	4.90%	—	—
	-27.37%	4.10%	—	—
	—	-0.53	4.46	—
	—	0.49	1.50	—
	—	0.05	0.01	—
	—	3.72	-0.03	—
	—	55.3	40.5	—
Balance sheet
	—	124.83	112.27	—
	—	85.41	70.82	—
	—	0.46	0.85	—
	—	38.65	30.61	—
	—	10.60	9.81	—
	—	6.41	2.34	—
	—	37.01	38.72	—
	—	21.70	21.24	—
	—	31.67	26.17	—
	—	4.18	0.82	—
	—	3.73	0.37	—
	—	0.45	0.45	—
	—	91.57	85.10	—
Cash flow
	—	4.13	12.09	—
	—	-4.96	-8.23	—
	—	0.44	-4.21	—
	—	4.66	7.63	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +1.13%
Profit YoY (TTM): -27.37%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 38.98%

Quarter	September 2026	June 2026
Promoter %	38.98%	38.98%

Holder	Type	Holding	Previous	Change
Anar Himanshu Patel	Promoter	21.70%	21.70%	0.00%
Himanshu Chaitanya Patel	Promoter	14.76%	14.76%	0.00%
V-S Holding B.V.	Public	14.71%	20.74%	-6.03%
Own Infracon Private Limited	Public	7.56%	8.63%	-1.07%
Kanchan Pramodkumar Daga	Public	5.78%	5.78%	0.00%
Nirmal Himanshu Patel	Promoter	2.52%	2.52%	0.00%
Varun Daga	Public	1.70%	1.70%	0.00%
Shreans Daga	Public	1.66%	1.66%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Denis Chem Lab Limited S	83	60.01	16.05	13.70%	+1.13% TTM	-27.37% TTM	-34.58%

Filings & corporate actions

Recent announcements

Unaudited Financial Results for the Quarter ended 30th September, 2026 along with Limited Review Report thereon.4 Nov 2026 · Result / Financial Results
The Board of Directors in their meeting held today, have taken on record the Un-audited Financial Results for the Quarter ended on 30th September, 2026.4 Nov 2026 · Board Meeting / Outcome of Board Meeting
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....23 Oct 2026 · Board Meeting / Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding B V16 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
We are herewith submitting the Certificate issued by MUFG Intime India Private Limited, RTA of the Company for the Quarter ended on 30th September, 20267 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform you that in terms of Company''s Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed from 1st October, 2026 till 48 hours ....26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company''s Annual General Meeting held today i.e. on 25th September, 2026, through VC/ ....25 Sep 2026 · Company Update / Change in Management
With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company's Annual General Meeting held today i.e. on 25th September, 2026, through VC/ ....25 Sep 2026 · Company Update / Change in Management
With reference to our letter dated 29th July, 2026, this is to inform you that the Shareholders/ Members in their 45th Annual General Meeting (AGM) held on Friday, the 25th September, 2026 ....25 Sep 2026 · Company Update / General
Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer''s Report.25 Sep 2026 · AGM/EGM / AGM
Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer''s Report.25 Sep 2026 · AGM/EGM / AGM
We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Conferencing (''''VC'''')/ Other Audio-Visual ....25 Sep 2026 · AGM/EGM / AGM
We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Conferencing (''''VC'''')/ Other Audio-Visual ....25 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holdings BV4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
We are enclosing herewith Clipping of Newspaper advertisement for 45th Annual General Meeting of the Company Published on 20th August, 2026.20 Aug 2026 · Company Update / Newspaper Publication
Notice Of 45th AGM Along With Annual Report 2025-2618 Aug 2026 · Company Update / General
Submission of Notice of 45th AGM along with Annual Report 2025-26.18 Aug 2026 · AGM/EGM / AGM
We are enclosing herewith Annual Report for FY 2025-26 along with Notice of 45th Annual General Meeting of the members of the Company.18 Aug 2026 · Others / Reg. 34 (1) Annual Report
Find Attach Newspaper Publication14 Aug 2026 · Company Update / Newspaper Publication
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....13 Aug 2026 · Result / Financial Results
The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2026. We are enclosing herewith copy of the ....13 Aug 2026 · Board Meeting / Outcome of Board Meeting
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....6 Aug 2026 · Board Meeting / Board Meeting
The Company has Informed exchange about copy of newspaper publication.3 Aug 2026 · Company Update / Newspaper Publication
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding BV1 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VS Holding BV31 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Board of Directors in their meeting held today reappointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 years with effect from 1st August, 2026 subject ....29 Jul 2026 · Company Update / Change in Directorate
Pursuant to regulation 42 of SEBI (LODR), Regulations, The Board of Directors in their meeting held today have fixed Friday, 18th September, 2026 as Record date for determining the members ....29 Jul 2026 · Corp. Action / Dividend
The Board of Directors in their meeting held today have Re-appointed Mr. Himanshu C. Patel as Managing Director of the Company for the period of 3 years with effect from 1st August, 2026 ....29 Jul 2026 · Company Update / Change in Directorate
Intimation regarding appointment of secretarial Auditor of the Company for the term of 5 year subject to approval of shareholders/ Members in ensuing Annual General Meeting.29 Jul 2026 · Company Update / Change in Management
The Board of Directors of the Company in their meeting held today decided the date of Board Meeting, Record date for Dividend, E-voting for AGM and other matters.29 Jul 2026 · AGM/EGM / AGM
The Board of Directors in their Meeting held today has decided Date of Annual General Meeting, record date for Dividend, Evoting for AGM and other matters.29 Jul 2026 · Others / Outcome without intimation
We are herewith submitting the Certificate issued by MUFG Intime India Private Limited, RTA of the Company for the Quarter ended on 30th June, 20267 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform you that in terms of Company''s Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain Closed w.e.f. 1st July,2026 till 48 hours ....23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The Board of Directors in their meeting held today recommended a final dividend of Rs. 2.5/- (@25%) per equity share of Rs. 10/- each for the financial year 2025-26 subject to approval ....30 May 2026 · Corp. Action / Dividend
Intimation of Appointment of Secretarial Auditors of the Company due to casual vacancy caused due to resignation of secretarial auditors.30 May 2026 · Company Update / General
The Board of Directors in their meeting held today have considered and approved the appointment of M/s. Kashyap R. Mehta and Partners as secretarial auditor to fill the casual vacancy caused ....30 May 2026 · Company Update / Change in Management
Audited Financial Results for financial year ended on 31st, March, 2026 along with Auditors report thereon.30 May 2026 · Result / Financial Results
the Board of Directors of the Company, in their meeting held today i.e. on 30th May, 2026, interalia, has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter ....30 May 2026 · Board Meeting / Outcome of Board Meeting
We are attaching herewith Annual Secretarial Compliance Report for the year 2025-26 issued by M/s. kashyap R Mehta and Partners, Company Secretaries.23 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve and take on record the Audited ....21 May 2026 · Board Meeting / Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.5000	18 Sep 2026	18 Sep 2026	—
Final Dividend - Rs. - 1.5000	19 Sep 2025	19 Sep 2025	—
Final Dividend - Rs. - 2.5000	19 Sep 2024	—	—

Board meetings

4 Nov 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results